HeadlinesBriefing favicon HeadlinesBriefing

Sector Investment 3 Days

×
6 articles summarized · Last updated: v1903
You are viewing an older version. View latest →

Last updated: August 21, 2026, 9:41 PM ET

Healthcare Private Equity

Specialist healthcare assets stayed in demand over the past three days. SkyKnight Capital has entered into a definitive agreement to invest in Apex Infusion, deepening its exposure to the fast-growing infusion services market. In parallel, Warburg Pincus is leading an investor group taking a controlling interest in PANTHERx Rare, a rare-disease pharmacy provider, in a transaction valued near $7bn. Together, the two deals signal that buyout firms still see durable cash flows in niche clinical platforms even as overall dealmaking remains selective.

AI Infrastructure

Technology and infrastructure investing converged further this week. Nvidia and its partners have pledged $500bn to establish compute capacity as a new "investable asset class," though skeptics question whether allocators will treat AI facilities like traditional infrastructure. A fresh paper from Houlihan Lokey frames the buildout as a virtuous circle linking energy and digital assets, with data-center power demand recycling into grid investment. For general partners, the prize is access to the largest capital-raising theme since renewables.

Renewables Fundraising

Fundraising momentum was mixed across clean energy. Copenhagen Infrastructure Partners reached a $3bn final close for its second growth-markets renewables strategy, with partner Niels Holst attributing the outcome to strong support from existing investors despite geopolitical headwinds. By contrast, Korea's National Pension Service posted infrastructure AUM growth of just 13.4% in 2024, down sharply from 24.2% in 2023, a sign that even the deepest pools of institutional capital are pacing their commitments more cautiously.